AtaiBeckley (ATAI) Gains from Investment Securities (2020 - 2024)
AtaiBeckley (ATAI) posted Gains from Investment Securities of $3.8 million for Q2 2025, up 82.84% sequentially from $2.1 million in Q4 2024.
Analysis
AtaiBeckley (ATAI) Gains from Investment Securities (2020 - 2024) Analysis & Trends
AtaiBeckley has reported Gains from Investment Securities for 6 years, with the latest figure at $3.8 million in Q2 2025.
- Quarterly Gains from Investment Securities changed N/A year-over-year to $3.8 million in Q2 2025, while the trailing twelve-month figure through Sep 2025 was $5.9 million (up 245.03% YoY) and the FY2024 annual result came in at $2.1 million, changed N/A from the prior year.
- Gains from Investment Securities improved to $3.8 million in Q2 2025 per ATAI's latest filing, from $2.1 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $16.5 million in Q4 2022 and troughed at -$469000.0 in Q3 2021.
- A 5-year average of $2.3 million and a median of $972000.0 in 2021 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2021 and 2022: Gains from Investment Securities sank 645.35% in 2021, then soared 4641.48% in 2022.
- Over 5 years, Gains from Investment Securities stood at -$364000.0 in 2021, then jumped by 4641.48% to $16.5 million in 2022, then plunged by 99.65% to $58000.0 in 2023, then soared by 3477.59% to $2.1 million in 2024, then soared by 82.84% to $3.8 million in 2025.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $3.8 million, $2.1 million, and $1.7 million for Q2 2025, Q4 2024, and Q1 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | AtaiBeckley | 1.61 Bn | 1.61 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 101,000.00 |
| Jun 30, 2024 | 273,000.00 |
| Mar 31, 2024 | 1.70 Mn |
| Dec 31, 2023 | 394,000.00 |
| Sep 30, 2023 | 58,000.00 |
| Jun 30, 2023 | -76,000.00 |
| Mar 31, 2023 | 1.03 Mn |
| Dec 31, 2022 | 1.33 Mn |
| Sep 30, 2022 | -430,000.00 |
| Jun 30, 2022 | -95,000.00 |
| Mar 31, 2022 | 5.60 Mn |
| Dec 31, 2021 | 49.12 Mn |
| Sep 30, 2021 | -469,000.00 |
| Jun 30, 2021 | 911,000.00 |
| Mar 31, 2021 | 1.70 Mn |
| Dec 31, 2020 | 2.81 Mn |
| Sep 30, 2020 | 86,000.00 |
| Jun 30, 2020 | 42,000.00 |